When Sam Hoare and the CRF receptor team at Neurocrin Biosciences discovered that their lead compound perspective to GPCR pharmacology — one trained in allosteric modulation, sharpened in Class B receptor biology For Hoare, the unsolved problem isn't the biology — it's the math no one wrote down. Hoare now consults for biotech and pharmaceutical clients on GPCR data analysis, receptor binding kinetics He guided the in vitro biology efforts of the company for numerous drug discovery campaigns.

simulation methods at University of Southern California, and at Caltech, she became the director of biomolecular She is an internationally recognized biophysicist for her contributions in developing constrained molecular

program in the Department of Pharmaceutical Sciences at the Faculty of Pharmacy and the Department of Biochemistry He is the scientific founder of two biotech companies, ModMab Therapeutics , and AntlerA Therapeutics Angers was named Director of the Donnelly Centre of Cellular and Biomolecular Research at the University

studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models.

Moro, that he truly saw how molecules could go beyond the bench and interact with biology in powerful The Moment Chemistry Met Biology Nicoli’s turning point came when he realized that molecules weren’t static—they could act , bind , and modulate biological targets. For Nicoli, chemistry became more than reactions—it became a bridge to biological insight. Alessandro Nicoli on the web Leibniz Institute for Food Systems Biology at the Technical University of

Pierre Eftekhari "Clinical physiologist and biologist , with more than 25 years of experience in drug Inoviem scientific in Nov. 2011 by myself we have been regularly working with GPCRs for our pharma and biotech

GPCR Ecosystem About Monserrat Avila Zozaya I am a cell biologist interested in studying GPCRs, especially Berchiche obtained her Master’s and Ph.D. in Biochemistry at the University of Montreal in Canada before expertise over the past two decades studying structure/function relationships of GPCRs using live-cell bioluminescence

melanocortin receptor accessory protein 2 (MRAP2), resulting in my first peer-reviewed publication in Biochimica et Biophysica Acta (BBA). In 2017 I officially joined the PhD program in the Department of Molecular Physiology and Biophysics While writing my thesis, I published another paper in the Journal of Biological Chemistry which described At this point in my career, I am creating connections with biomedical industry, assessing professional

More broadly, I hope to be a critical contributor to a growing Canadian biotech sector in both scientific

How collaborations with David Parker and Jean-Philippe Pin accelerated both probe chemistry and biological the unpredictability of product development, Or felt the thrill of seeing a tool you built drive real biological Eric Trinquet is Head of R&D for Life Sciences Reagents at Revvity, where he leads innovation in biochemical With a foundational career at Cisbio Bioassays—later acquired by Revvity—Eric played a pivotal role in

Stalled Pipeline Progression ❌ Uncertainty in GPCR Investments Advisory Focus Areas Expert support for Biotech innovators, VC investors and CRO partners Biotech Pipeline Acceleration For Biotech Leaders & Scientists I integrate seamlessly with biotech, VC, and CRO teams as a trusted, objective partner. Biology-First, Data-Driven Solutions Every recommendation is rooted in GPCR biology, pharmacology experience With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector

GPCR x Celtarys Reseach Empowering medicinal biochemists Celtarys empowers medicinal biochemists by providing focuses on organic synthesis, medicinal chemistry, and the development of GPCR-targeted tools for pharma, biotech Celtarys Research develops high-quality, fluorescently labeled ligands and innovative chemical biology analysis, and live-cell imaging, empowering both academic and industrial scientists to uncover GPCR biology will help accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology

Chemical biologist Johannes Broichhagen reveals how fluorescent probes transform GPCR imaging, internalization GPCR Podcast, chemical biologist Dr. Why this matters How a chemist with zero biology training became a leader in GPCR probe design. Who should listen If you’ve ever: Navigated a project where the biology refused to match the textbook Collaborated across chemistry and biology and felt the translation gap firsthand… …this episode will

A fungal serine protease allergen with GPCR-modulating features was discovered as a new biomarker and

podcast list Strategic Partner(s) Gáspár Pándy-Szekeres About Gáspár Pándy-Szekeres " After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's group as a bioinformatician.

Pittsburgh and continued her postdoctoral research at the University of Vermont studying cellular signaling, biosensors Nyla supports biomedical research by connecting researchers with resources and promoting reproducible I completed my Ph.D. in molecular and cell biology at UConn and then joined Addgene as a Quality Control

Maria Waldhoer, CSO of InterAx Biotech AG, argues that endpoint assays — the field's default way of characterizing Maria Waldhoer is Chief Scientific Officer at InterAx Biotech AG in Switzerland. She has been at InterAx since 2017, where she leads the development of a computational systems biology 25:26 — The HEK293 experiment that predicted the animal 31:21 — Tools for the next decade: biosensors Maria Waldhoer on the web LinkedIn InterAx Biotech Pubmed Dr. GPCR Ecosystem Unlock the Full Dr.

What challenges do you face most in your research or biotech journey?

is an online platform that provides to (i) individuals and businesses such as scientists, students, biotech others with access to advertise, to promote, and market their services and products related to the biotech

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

Velazhahan About Vaithish Velazhahan Vaithish obtained dual bachelor’s degrees with honors in Medical Biochemistry His undergraduate thesis work on studying the biochemical mechanisms of flavonoids in cancer using nuclear received a prestigious Gates Cambridge Scholarship to study for a Ph.D. at the MRC Laboratory of Molecular Biology

Andrew Tobin Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining research laboratory of around 15 staff supported by basic research grants investigating aspects of disease biology Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology

GPCR Retreat — an immersive event uniting scientists, biotech leaders, and innovators in GPCR research

FB is recognized for her expertise and pioneering works in the field of biological and pathological functions

GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well

culture of normal and malignant pancreatic tissue, allowing advances in sequencing, target discovery and biomarker interest in science originated from a young age and his desire to gain more knowledge about cancer biology They also shared their personal experiences and interest in the field of biology. proposed further exploration of dosage and length of treatment in a mouse model and suggested using a biosensor-based

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology

Bianca Plouffe obtained her B.Sc. in Biochemistry in 2003 from Université de Sherbrooke (Qc, Canada). As part of Bouvier’s team, Bianca used Bioluminescence Resonance Energy Transfer (BRET)-based technology

She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced Her research focuses on understanding the fundamental cell biological mechanisms regulating GPCR activity Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

Zhao is a Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), Drug Discovery Biology Working alongside structural biologists, computational pharmacologists, and receptor scientists working 32:30 From PAR2 to GLP-1 - building the mechanistic picture one step at a time 37:01 GLP-1 receptor biology